Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001

類似資料

• Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells
  著者:: Catley, Laurence, 等
  出版事項: (2006)
• Inhibitor of Apoptosis Proteins (IAPs) as therapeutic targets in Multiple Myeloma (MM)
  著者:: Ramakrishnan, Vijay, 等
  出版事項: (2014)
• Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma
  著者:: Ramakrishnan, Vijay G., 等
  出版事項: (2019)
• Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells
  著者:: Yan-Fang, Tao, 等
  出版事項: (2015)
• Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma
  著者:: Ramakrishnan, Vijay, 等
  出版事項: (2016)